JOSHUA JIMERSON: Open Payments
NPI 1649951989 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,077 in 173 payments from 33 companies in 2025. Trend: 2023 $0 · 2024 $301 · 2025 $3,077
Food & beverage: $3,077
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $339 |
| ABBVIE INC. | 14 | $311 |
| UCB, Inc. | 13 | $204 |
| Neurocrine BioSciences, Inc. | 10 | $179 |
| PFIZER INC. | 11 | $171 |
| EMD Serono, Inc. | 7 | $155 |
| Genentech USA, Inc. | 12 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $146 |
| Averitas Pharma Inc. | 7 | $140 |
Products named: UPLIZNA, BOTOX, Rystiggo, INGREZZA, NURTEC ODT, KESIMPTA, HYQVIA, Ocrevus Zunovo.
Industry payments across NY — which companies pay providers there.
